Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q8N5S9
UPID:
KKCC1_HUMAN
Alternative names:
CaM-kinase IV kinase; Calcium/calmodulin-dependent protein kinase kinase alpha
Alternative UPACC:
Q8N5S9; Q9BQH3
Background:
Calcium/calmodulin-dependent protein kinase kinase 1 (CaMKK1) is a pivotal enzyme in calcium-triggered signaling cascades, phosphorylating a range of targets including CAMK1, CAMK1D, CAMK1G, and CAMK4. Its role extends to crucial cellular processes such as apoptosis regulation, where it fosters cell survival by activating AKT1/PKB to inhibit the pro-apoptotic factor BAD/Bcl2-antagonist of cell death.
Therapeutic significance:
Understanding the role of Calcium/calmodulin-dependent protein kinase kinase 1 could open doors to potential therapeutic strategies, particularly in manipulating cell survival pathways for disease intervention.